Further increased expression of integrin β3 led to increased myeloid maturation and a deceleration of leukemic progression, while a decrease of fibronectin expression in BCR-ABL1+ cells accelerated the disease similar to BCR-ABL1T315I+ CML. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.